header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

SURGICAL TREATMENT OF CLAVICLE FRACTURE USING A CONGRUENT ANATOMICAL PLATE



Abstract

Fracture of the clavicle is common and comprise 4% of all adult fractures. The incidence appears to be increasing owing to several factors, including the occurrence of many more high velocity vehicular injuries and an increase in popularity of contact sports. The most common side site for occurrence of fracture in clavicle is the middle third and the medial fractures are rare.

We did our retrospective study during 2003–2005. We review 13 patients with fracture of the clavicle. There were 10 males and 3 females and 11 were left side and 2 were right side. Patients ages ranged between 15–49 years (average 29.6). The majority of fractures were caused by motorbike and quads bike accidents. 10 were classified as Neer type 1 (midshaft) and 3 were Neer type 1 (distal third). All these patients were treated with an Acumed congruent anatomical plate. The patients were followed up for 6 months to 1 years. Post-operatively patients were treated for 3 weeks in a sling, and then had physiotherapy for the next 3 weeks. All fractures were united by 7 weeks. Our complications were 1 superficial wound infection, 1 delayed union at 9 weeks, and 1 non union at 12 weeks. All patients had a full range of movement of the shoulder by the end of the 6th week.

In the past fractures of the clavicle were treated conservatively. Currently patients want to mobilise their limbs early, and get back to work. The clinical results of the congruent anatomical plate appear to be good in terms of fracture union and early return to function in young patients. The principal advantage of this method of treatment is an anatomical reduction of the fracture and early rehabilitation with return to normal function.

Correspondence should be addressed to: Léana Fourie, CEO SAOA, PO Box 12918, Brandhof 9324 South Africa.